You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

List of Excipients in API buprenorphine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing buprenorphine hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Indivior Inc BUPRENEX buprenorphine hydrochloride 12496-0757 ANHYDROUS DEXTROSE
Indivior Inc BUPRENEX buprenorphine hydrochloride 12496-0757 HYDROCHLORIC ACID
Indivior Inc BUPRENEX buprenorphine hydrochloride 12496-0757 WATER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing buprenorphine hydrochloride

Company Ingredient NDC Excipient
PAI Holdings LLC dba Pharmaceutical Associates Inc and dba PAI Pharma buprenorphine hydrochloride 0121-1019 ANHYDROUS CITRIC ACID
PAI Holdings LLC dba Pharmaceutical Associates Inc and dba PAI Pharma buprenorphine hydrochloride 0121-1019 LACTOSE MONOHYDRATE
PAI Holdings LLC dba Pharmaceutical Associates Inc and dba PAI Pharma buprenorphine hydrochloride 0121-1019 MANNITOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for buprenorphine hydrochloride

Excipient focus: .ALPHA.-TOCOPHEROL ACETATE

Excipient focus: ACESULFAME POTASSIUM

buprenorphine hydrochloride drug variants containing ACESULFAME POTASSIUM

Company Ingredient NDC
PAI Holdings LLC dba Pharmaceutical Associates Inc and dba PAI Pharma buprenorphine hydrochloride and naloxone hydrochloride 0121-1018
Akorn Operating Company LLC (dba Akorn) buprenorphine hydrochloride and naloxone hydrochloride 50383-294
Aidarex Pharmaceuticals LLC buprenorphine hydrochloride and naloxone hydrochloride 53217-138
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DEXTROSE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DEXTROSE

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTITOL

Excipient focus: MANNITOL

Excipient focus: MENTHOL

Excipient focus: METHYLPARABEN

Excipient focus: PEPPERMINT OIL

Excipient focus: POLYCARBOPHIL

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links